Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
- Biohaven Pharmaceutical Holding Company Ltd (NYSE:BHVN) has announced results from a focused analysis of verdiperstat trial in verdiperstat in multiple system atrophy (MSA).
- Verdiperstat did not differ statistically from placebo on the prespecified primary efficacy measure or the key secondary efficacy measures.
- Initial safety data were consistent with the overall profile of verdiperstat from prior clinical trial experience.
- Additional analyses are still pending, and full study results will be presented at an upcoming scientific meeting.
- An ongoing amyotrophic lateral sclerosis (ALS) trial of verdiperstat is conducted with the Sean M. Healey & AMG Center at Massachusetts General Hospital. Enrollment will be completed in Q4 of 2021.
- MSA is a rare, rapidly progressive fatal neurodegenerative disease that leads to death within a median of 6-10 years after the onset of symptoms.
- Read Next: Eli Lilly To Test Injectable Migraine Med Against Biohaven's Oral Nurtec In Head-To-Head Study.
- Price Action: BHVN stock is down 3.81% at $126.96 during the premarket session on the last check Monday.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!